Literature DB >> 215728

Muscle hypertrophy with neuropathy.

A D Korczyn, A Kuritzky, U Sandbank.   

Abstract

A patient with insidious onset of weakness, muscle atrophy and true hypertrophy, and sustained spasms is described. The spasms, initially mistaken to be myotonic, were shown electromyographically to result from sustained activity of the muscle fibres. An additional clinical manifestation verified myographically, was impaired reciprocal inhibition. Also, the patient had thick peripheral nerves and very slow motor (but normal sensory) nerve conduction. Histologic examination of sural nerve biopsy revealed large vacuoles within Schwann cells containing unidentified material, as well as onion-bulb formations. The possibility of a metabolic error resulting in storage of an abnormal material within Schwann cells is assumed.

Entities:  

Mesh:

Year:  1978        PMID: 215728     DOI: 10.1016/0022-510x(78)90145-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

1.  Unilateral true hypertrophy of the calf muscle.

Authors:  S Ono; Y Kuroiwa; H Miyajima; Y Nishimura; N Honda
Journal:  J Neurol       Date:  1985       Impact factor: 4.849

2.  Asymmetric calf hypertrophy of neurogenic origin.

Authors:  Hajnalka Merkli; Endre Pál; István Gáti
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

3.  Muscle hypertrophy and a syndrome of continuous motor unit activity in prednisone-responsive Guillain-Barré polyneuropathy.

Authors:  C Vasilescu; M Alexianu; A Dan
Journal:  J Neurol       Date:  1984       Impact factor: 4.849

4.  Neurogenic muscle hypertrophy. Report of two cases.

Authors:  D Pareyson; L Morandi; V Scaioli; R Marazzi; A Boiardi; A Sghirlanzoni
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

5.  Unilateral hypertrophy of tensor fascia lata: a soft tissue tumor simulator.

Authors:  H Ilaslan; D E Wenger; T C Shives; K K Unni
Journal:  Skeletal Radiol       Date:  2003-09-30       Impact factor: 2.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.